MVMDF (Mountain Valley MD Holdings) 3-Year Dividend Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mountain Valley MD Holdings 3-Year Dividend Growth Rate?

Mountain Valley MD Holdings MVMDF -22.53% 3-Year Dividend Growth Rate is 0.00% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 350 Drug Manufacturers companies, Mountain Valley MD Holdings ranks worse than 285714% on this metric.

Mountain Valley MD Holdings's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The historical rank and industry rank for Mountain Valley MD Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

MVMDF's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.7
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Mountain Valley MD Holdings's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Mountain Valley MD Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Mountain Valley MD Holdings  (OTCPK:MVMDF) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Mountain Valley MD Holdings's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 0
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings 3-Year Dividend Growth Rate Related Terms>


MVMDF vs ZTS: 3-Year Dividend Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings 3-Year Dividend Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's 3-Year Dividend Growth Rate falls into.



Mountain Valley MD Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Dividend Growth Rate of 0.00% mean?
Mountain Valley MD Holdings (MVMDF) has a 3-Year Dividend Growth Rate of 0.00% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Mountain Valley MD Holdings and its competitors. According to the industry distribution chart, Mountain Valley MD Holdings ranks #999999 out of 350 companies in the Drug Manufacturers industry.
Is Mountain Valley MD Holdings' 3-Year Dividend Growth Rate too high?
Mountain Valley MD Holdings' current 3-Year Dividend Growth Rate is 0.00%. Based on the distribution chart, Mountain Valley MD Holdings ranks #999999 out of 350 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Mountain Valley MD Holdings' 3-Year Dividend Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mountain Valley MD Holdings ranks #999999 out of 350 companies for 3-Year Dividend Growth Rate. This places Mountain Valley MD Holdings in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 3-Year Dividend Growth Rate among Drug Manufacturers companies is 7.70, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Mountain Valley MD Holdings and its competitors. For the Drug Manufacturers industry, the median 3-Year Dividend Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mountain Valley MD Holdings's current 3-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mountain Valley MD Holdings stock overvalued right now?
Mountain Valley MD Holdings (MVMDF) has a current 3-Year Dividend Growth Rate of 0.00%. The current 3-Year Dividend Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Mountain Valley MD Holdings (MVMDF), the current 3-Year Dividend Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mountain Valley MD Holdings Business Description

Other Exchanges 20MP:GermanyMVMD:Canada
Address 260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.